# University of Yamanashi Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-of-yamanashi-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 96.5 |
| Citations | 226,735 |
| City | Chūō |
| Country | JP |
| Description | University of Yamanashi Hospital is a research organisation in Chūō, JP. OpenAlex records 2,984 works and 226,735 citations for it. 869 researchers list it as their most recent affiliation. |
| Homepage | http://www2.hosp.yamanashi.ac.jp/english/ |
| OpenAlex ID | https://openalex.org/I4210112011 |
| Researchers | 869 |
| ROR ID | https://ror.org/022tqjv17 |
| Type | healthcare |
| Works | 2,984 |

## University papers

- [Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update](https://scholariq.org/papers/asian-pacific-clinical-practice-guidelines-on-the-management-of-hepatitis-b-a/)
- [Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update](https://scholariq.org/papers/asia-pacific-clinical-practice-guidelines-on-the-management-of-hepatocellular/)
- [Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma](https://scholariq.org/papers/correction-corrigendum-microrna122-is-a-key-regulator-of-fetoprotein-expression/)
- [Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma](https://scholariq.org/papers/asian-pacific-association-for-the-study-of-the-liver-consensus-recommendations/)
- [The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease](https://scholariq.org/papers/the-asian-pacific-association-for-the-study-of-the-liver-clinical-practice/)
- [New Inuyama classification; new criteria for histological assessment of chronic hepatitis](https://scholariq.org/papers/new-inuyama-classification-new-criteria-for-histological-assessment-of-chronic/)
- [Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)](https://scholariq.org/papers/pre-existing-liver-disease-is-associated-with-poor-outcome-in-patients-with-sars/)
- [Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update](https://scholariq.org/papers/asian-pacific-association-for-the-study-of-the-liver-apasl-consensus-guidelines/)

## University top topics

Showing 8 of 25.

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Spine and Intervertebral Disc Pathology](https://scholariq.org/topics/spine-and-intervertebral-disc-pathology/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [MRI in cancer diagnosis](https://scholariq.org/topics/mri-in-cancer-diagnosis/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.